| Primary |
| Computerised Tomogram |
12.5% |
| X-ray |
10.0% |
| X-ray With Contrast Upper Gastrointestinal Tract |
10.0% |
| Diagnostic Procedure |
7.5% |
| Breast Cancer Metastatic |
5.0% |
| Computerised Tomogram Abdomen |
5.0% |
| Deep Vein Thrombosis |
5.0% |
| Gun Shot Wound |
5.0% |
| Oesophageal Perforation |
5.0% |
| Product Used For Unknown Indication |
5.0% |
| Scan With Contrast |
5.0% |
| Small Intestinal Obstruction |
5.0% |
| Abdomen Scan |
2.5% |
| Abdominal Pain Upper |
2.5% |
| Barrett's Oesophagus |
2.5% |
| Catheter Placement |
2.5% |
| Diverticulitis |
2.5% |
| Drug Hypersensitivity |
2.5% |
| Fistulogram |
2.5% |
| Gallbladder Disorder |
2.5% |
|
| Unresponsive To Stimuli |
12.5% |
| Vomiting |
12.5% |
| Aspiration |
9.4% |
| Anaphylactoid Reaction |
6.3% |
| Drug Administration Error |
6.3% |
| Drug Ineffective |
6.3% |
| Product Quality Issue |
6.3% |
| Anaphylactic Reaction |
3.1% |
| Blood Thyroid Stimulating Hormone Increased |
3.1% |
| Death |
3.1% |
| Diarrhoea |
3.1% |
| Gastric Mucosal Hypertrophy |
3.1% |
| Hypotension |
3.1% |
| No Adverse Event |
3.1% |
| Pneumonia Aspiration |
3.1% |
| Product Odour Abnormal |
3.1% |
| Renal Failure |
3.1% |
| Renal Failure Acute |
3.1% |
| Renal Tubular Necrosis |
3.1% |
| Respiratory Failure |
3.1% |
|
| Secondary |
| Supplementation Therapy |
22.5% |
| Pancreatitis |
13.0% |
| Sedation |
6.8% |
| Constipation |
6.1% |
| Computerised Tomogram |
5.8% |
| Hypertension |
5.8% |
| Product Used For Unknown Indication |
4.8% |
| Pain |
4.1% |
| Thrombosis Prophylaxis |
4.1% |
| Withdrawal Syndrome |
4.1% |
| Prophylaxis |
3.8% |
| Alcohol Withdrawal Syndrome |
3.4% |
| Dyspnoea |
2.7% |
| Nausea |
2.7% |
| Prophylaxis Against Gastrointestinal Ulcer |
2.7% |
| Nuclear Magnetic Resonance Imaging |
2.0% |
| Cardiac Arrest |
1.4% |
| Drug Use For Unknown Indication |
1.4% |
| Endoscopy Upper Gastrointestinal Tract |
1.4% |
| Gastric Ulcer |
1.4% |
|
| Sleep Disorder |
15.8% |
| Toxic Epidermal Necrolysis |
10.5% |
| Urticaria |
10.5% |
| Aspiration |
7.9% |
| Vomiting |
7.9% |
| Drug Administration Error |
5.3% |
| Rash |
5.3% |
| Weight Decreased |
5.3% |
| Acute Respiratory Distress Syndrome |
2.6% |
| Anaphylactic Reaction |
2.6% |
| Blood Pressure Abnormal |
2.6% |
| Chills |
2.6% |
| Drug Hypersensitivity |
2.6% |
| Drug Ineffective |
2.6% |
| Hypotension |
2.6% |
| Neonatal Intestinal Obstruction |
2.6% |
| Renal Failure Acute |
2.6% |
| Respiratory Arrest |
2.6% |
| Respiratory Failure |
2.6% |
| Septic Shock |
2.6% |
|
| Concomitant |
| Product Used For Unknown Indication |
15.9% |
| Drug Use For Unknown Indication |
15.5% |
| Computerised Tomogram Abdomen |
9.9% |
| Hypertension |
6.5% |
| Pain |
5.5% |
| Adverse Event |
4.6% |
| Prophylaxis |
4.2% |
| Sepsis |
4.0% |
| Febrile Neutropenia |
3.7% |
| Multiple Myeloma |
3.4% |
| Constipation |
3.3% |
| Prostate Cancer |
3.3% |
| Thrombosis Prophylaxis |
3.3% |
| Hepatic Neoplasm Malignant |
2.9% |
| Rash |
2.7% |
| Proteus Infection |
2.6% |
| Pseudomonas Infection |
2.6% |
| Pancreatitis |
2.3% |
| Ill-defined Disorder |
1.9% |
| Pyrexia |
1.9% |
|
| Urticaria |
25.6% |
| Vomiting |
11.1% |
| Stevens-johnson Syndrome |
7.8% |
| Faecaloma |
5.6% |
| Nausea |
5.6% |
| Sneezing |
5.6% |
| Gastrointestinal Perforation |
4.4% |
| Oropharyngeal Discomfort |
4.4% |
| Alanine Aminotransferase Increased |
3.3% |
| Anaemia |
3.3% |
| Unresponsive To Stimuli |
3.3% |
| Cardiac Arrest |
2.2% |
| Dyspnoea |
2.2% |
| Paraesthesia Oral |
2.2% |
| Peritonitis |
2.2% |
| Pneumonia |
2.2% |
| Pruritus |
2.2% |
| Rash Erythematous |
2.2% |
| Shock |
2.2% |
| Throat Irritation |
2.2% |
|
